Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura T Pierce

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos One|January 19, 2022
Quantitative, traceable determination of cell viability using absorbance microscopyGreta Babakhanova, Stephen M Zimmerman, Laura T Pierce, et al.
Blood|April 13, 2010
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignanciesRichard J Rickles, Laura T Pierce, Thomas P Giordano, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
Molecular Cancer Therapeutics|April 5, 2012
Adenosine A2A and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screeningRichard J Rickles, Winnie F Tam, Thomas P Giordano, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|January 19, 2022
Quantitative, traceable determination of cell viability using absorbance microscopyGreta Babakhanova, Stephen M Zimmerman, Laura T Pierce, et al.
Blood|April 13, 2010
Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignanciesRichard J Rickles, Laura T Pierce, Thomas P Giordano, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
Molecular Cancer Therapeutics|April 5, 2012
Adenosine A2A and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screeningRichard J Rickles, Winnie F Tam, Thomas P Giordano, et al.
Pageof 1